IDXX — IDEXX Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $35.45bn
- $36.03bn
- $3.90bn
- 99
- 13
- 86
- 73
Annual cashflow statement for IDEXX Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 582 | 745 | 679 | 845 | 888 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 39.8 | 47 | 60.6 | 67.3 | 68.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.8 | -138 | -274 | -72.4 | -133 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 648 | 756 | 543 | 907 | 929 |
| Capital Expenditures | -108 | -120 | -159 | -134 | -131 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.5 | -173 | -36.5 | 8.38 | -76.1 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -109 | -293 | -195 | -125 | -207 |
| Financing Cash Flow Items | -27.3 | -20.7 | -17.5 | -13.1 | -10.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -248 | -697 | -371 | -442 | -878 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 294 | -239 | -31.9 | 341 | -166 |